Skip to main content

Advertisement

SpringerLink
Log in

Treating headaches with botulinum toxin

  • Current Reality in Headache Treatments
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Botulinum toxin type A (BT-a) has been shown to effectively treat several types of neurological disorders. For over 15 years it has been used clinically also for the prophylaxis and treatment of various types of primary headache disorders. Although BT-a efficacy has not been proven in tension-type headache, its use in migraine continues to cause controversy. There is adequate data to support the hypothesis, beside its well known effect on acetylcholine release, of an additional antinociceptive effect related to a block in the local release of nociceptive neuropeptides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Collins A, Jankovic J (2006) Botulinum toxin injection for congenital muscular torticollis presenting in children and adults. Neurology 76:1083–1085

    Article  Google Scholar 

  2. Ewans RW, Blumenfeld A (2003) Botulinum toxin injections for headache. Headache 43:682–685

    Article  Google Scholar 

  3. Mathew NT, Kaup AO (2002) The use of botulinum toxin type A in headache treatment. Curr Treat Options Neurol 4:365–373

    Article  PubMed  Google Scholar 

  4. Simpson LL (1981) The origin, structure and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155–188

    PubMed  CAS  Google Scholar 

  5. Aoki KR (2001) Pharmacology and immunology of botulinum toxin serotypes. J Neurol 248[Suppl 1]:3–10

    Article  PubMed  CAS  Google Scholar 

  6. Purkiss J, Welch MKA, Doward S, Foster K (2000) Capsaicinstimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms. Biochem Pharmacol 59:1403–1406

    Article  PubMed  CAS  Google Scholar 

  7. Durham PL, Cady R, Cady R (2004) Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44:35–43

    Article  PubMed  Google Scholar 

  8. Schulte-Mattler WJ, Martinez-Castrillo JC (2006) Botulinum toxin therapy of migraine and tension-type headache. Eur J Neurol 13[Suppl 1]:51–54

    Article  PubMed  Google Scholar 

  9. Blumenfeld AM (2003) Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders. Headache 43:853–860

    Article  PubMed  Google Scholar 

  10. Saper JR, Mathew NT, Loder EW et al (2007) A double-blind, randomized, placebo-controlled comparison of botulinum toxin type A injection sites and doses in the prevention of episodic migraine. Pain Med 8:478–485

    Article  PubMed  Google Scholar 

  11. Tepper S, Bigal M, Sheftell F, Rapoport A (2004) Botulinum neurotoxin type A in the preventive treatment of refractory headache. Headache 44:749–800

    Google Scholar 

  12. Mathew N, Frishberg BM, Gawel et al (2005) Botulinum toxin type A for the prophylactic treatment of chronic daily headache. Headache 45:293–307

    Article  PubMed  Google Scholar 

  13. Ondo WG, Voung KD, Derman HS (2004) Botulinum toxin A for chronic daily headache. Cephalalgia 24:60–65

    Article  PubMed  CAS  Google Scholar 

  14. Schulte-Mattler WJ, Krack P (2004) Treatment of chronic tension-type headache with botulinum toxin A. Pain 109:110–114

    Article  PubMed  CAS  Google Scholar 

  15. Goadsby P (2007) Emerging therapies for migraine. Nat Clin Pract Neurol 3:610–619

    Article  PubMed  CAS  Google Scholar 

  16. Olesen J, Bousser M-G, Diener H-C et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746

    Article  PubMed  CAS  Google Scholar 

  17. Silberstein SD, Stark SR, Lucas SM et al (2005) Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 80:1126–1137

    Article  PubMed  CAS  Google Scholar 

  18. Mathew NT, Frishberg BM, Gawel M et al (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 45:293–307

    Article  PubMed  Google Scholar 

  19. Dodick DW, Mauskop A, Elkind AH et al (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45:315–324

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurological Department, Via E. Raggio 12, 15057, Novi Ligure, Italy

    Marco Aguggia

Authors
  1. Marco Aguggia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marco Aguggia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aguggia, M. Treating headaches with botulinum toxin. Neurol Sci 29 (Suppl 1), 137–139 (2008). https://doi.org/10.1007/s10072-008-0905-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-008-0905-6

Keywords

Search

Navigation